Skip to content
Trial Eligibility
Menu

Breast Cancer Clinical Trials near Miami, FL

74 studies for Breast Cancer are recruiting at 173 sites within 50 miles of Miami, Florida, according to ClinicalTrials.gov data processed .

Distances are city-level approximations. See all Breast Cancer trials in the US or all trials near Miami.

Your ZIP is looked up in your browser. We don't receive or store it.

Recruiting now

Breast Cancer studies enrolling near Miami

Showing the 50 nearest of 74 studies.
  1. Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

    NCT05879926

    • Phase 3
    • Ages 18 to 60 years
    • Sex: Female

    Nearest sites: Miami Cancer Institute (Miami, FL); UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    14 sites within 50 mi
  2. ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

    NCT06876714

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL); University of Miami Miller School of Medicine-Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    10 sites within 50 mi
  3. De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

    NCT04852887

    • Phase 3
    • Ages 50 to 70 years
    • Sex: All

    Nearest sites: University of Miami Miller School of Medicine-Sylvester Cancer Center (Miami, FL); Mount Sinai Medical Center (Miami Beach, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  4. Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

    NCT06072612

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: University Of Miami-SCCC-Miami (Miami, FL); University of Miami_SCCC - Kendall (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  5. Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

    NCT06500481

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute (Miami, FL); UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    8 sites within 50 mi
  6. Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

    NCT05564377

    • Phase 2
    • Ages Any age
    • Sex: All

    Nearest sites: UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL); University of Miami Miller School of Medicine-Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  7. Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

    NCT05929768

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute (Miami, FL); Mount Sinai Medical Center (Miami Beach, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    7 sites within 50 mi
  8. Testing the Addition of an Individualized Vaccine to Durvalumab and Tremelimumab and Chemotherapy in Patients With Metastatic Triple Negative Breast Cancer

    NCT03606967

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: UM Sylvester Comprehensive Cancer Center at Kendall (Miami, FL); University of Miami Miller School of Medicine-Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    6 sites within 50 mi
  9. A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

    NCT06492616

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health Inc. (Miami, FL); University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  10. MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

    NCT03053193

    • Observational
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health, Inc (Miami, FL); Sylvester Comprehensive Cancer Center - University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    3 sites within 50 mi
  11. Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

    NCT04468061

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute at Baptist Health (Kendall) (Miami, FL); Miami Cancer Institute at Baptist Health (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  12. ATEMPT 2.0: Adjuvant T-DM1 vs TH

    NCT04893109

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute/Baptist Hospital of Miami (Miami, FL); Miami Cancer Institute - Plantation (MCIP) (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  13. Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

    NCT05696626

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute (Miami, FL); Miami Cancer Institute Plantation (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  14. Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy

    NCT05856773

    • Phase 3
    • Ages 19 years and older
    • Sex: Female

    Nearest sites: Dwoskin Proton Therapy Center (Miami, FL); Miami Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  15. A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)

    NCT06103864

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Research Site (Miami, FL); Research Site (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  16. The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

    NCT06377852

    • Phase 3
    • Ages 60 years and older
    • Sex: All

    Nearest sites: Miami Cancer Institute (Miami, FL); Miami Cancer Institute (Plantation, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  17. Breast Re-irradiation After Second Ipsilateral Lumpectomy

    NCT06867484

    • Interventional
    • Ages 40 years and older
    • Sex: Female

    Nearest sites: Miami Cancer Institute at Baptist Health, Inc. (Miami, FL); Lynn Cancer Institute at Baptist Health, Inc. (Boca Raton, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    2 sites within 50 mi
  18. Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

    NCT02620852

    • Interventional
    • Ages 30 to 74 years
    • Sex: Female
    • Accepts healthy volunteers

    Nearest site: TopLine MD Alliance (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  19. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    NCT03452774

    • Observational
    • Ages Any age
    • Sex: All

    Nearest site: Massive Bio SYNERGY-AI site (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  20. Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

    NCT03808337

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baptist Alliance - McI (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  21. Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer

    NCT04084730

    • Phase 2
    • Ages 45 years and older
    • Sex: Female

    Nearest site: Baptist Alliance Miami Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  22. SABER Study for Selected Early Stage Breast Cancer

    NCT04360330

    • Interventional
    • Ages 50 years and older
    • Sex: Female

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  23. The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

    NCT04585750

    • Phase 1/2
    • Ages 12 years and older
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  24. Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences

    NCT04650256

    • Interventional
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  25. Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

    NCT05232916

    • Phase 3
    • Ages 18 to 100 years
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  26. cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

    NCT05366881

    • Observational
    • Ages 40 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: Miami Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  27. Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer

    NCT05455619

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Miami Cancer Institute at Baptist Health (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  28. A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

    NCT05503797

    • Phase 2
    • Ages 8 years and older
    • Sex: All

    Nearest site: University of Miami Hospital and Clinics (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  29. A Study of SDX-7320 in Combination With Eribulin for People With Breast Cancer

    NCT05570253

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: BAPTIST ALLIANCE - MCI (Data Collection Only) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  30. With Love, Grandma ("Con Cariño, Abuelita") Pilot Study

    NCT05721976

    • Interventional
    • Ages 21 years and older
    • Sex: Female

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  31. Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

    NCT05983432

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  32. Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer

    NCT06123988

    • Interventional
    • Ages 18 years and older
    • Sex: Female

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  33. DATO-BASE: DATOpotamab-deruxtecan for Breast Cancer Brain metAstaSEs

    NCT06176261

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Miami Baptist Cancer Institute/ (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  34. Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

    NCT06239194

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center - University of Miami Health System (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  35. A Phase 1/1b Study of IAM1363 in HER2 Cancers

    NCT06253871

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  36. Sequencing Antibody Drug Conjugates in ER+/HER2 LOW/ULTRA LOW MBC

    NCT06263543

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Baptist Health Herbert Wertheim Cancer Institute (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  37. Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

    NCT06293898

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  38. Precise Oncology Interventions in Nutrition and Training (OnPoint)

    NCT06534918

    • Interventional
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  39. A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors

    NCT06618287

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami Hospital and Clinics, Sylvester Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  40. First in Human Study of TUB-030 in Patients With Advanced Solid Tumors

    NCT06657222

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  41. A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

    NCT06778863

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: University of Miami - Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  42. A Study of Breast Cancer Risk Factors and Outcomes of People in Florida

    NCT06780176

    • Observational
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of Miami (Data Collection Only) (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  43. A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients

    NCT06934239

    • Phase 4
    • Ages 18 years and older
    • Sex: All
    • Accepts healthy volunteers

    Nearest site: University of Miami Health System (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  44. ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer

    NCT07007559

    • Phase 2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  45. A Study of [225Ac]Ac-AKY-1189 in Patients With Solid Tumors

    NCT07020117

    • Phase 1
    • Ages 18 years and older
    • Sex: All

    Nearest site: Biogenix Molecular, LLC (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  46. A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer

    NCT07100106

    • Phase 1/2
    • Ages 18 years and older
    • Sex: All

    Nearest site: Sylvester Comprehensive Cancer Center (Miami, FL)

    Distance to nearest recruiting site
    <1 mi (city-level)
    Recruiting sites
    1 site within 50 mi
  47. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    NCT05334069

    • Observational
    • Ages 40 to 75 years
    • Sex: All
    • Accepts healthy volunteers

    Nearest sites: Mount Sinai Medical Center (Miami Beach, FL); Mount Sinai Comprehensive Cancer Center at Aventura (Aventura, FL)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    5 sites within 50 mi
  48. S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

    NCT03723928

    • Interventional
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Medical Center (Miami Beach, FL); Mount Sinai Comprehensive Cancer Center at Aventura (Aventura, FL)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  49. Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

    NCT05812807

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Medical Center (Miami Beach, FL); Memorial Hospital West (Pembroke Pines, FL)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    4 sites within 50 mi
  50. Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer

    NCT06058377

    • Phase 3
    • Ages 18 years and older
    • Sex: All

    Nearest sites: Mount Sinai Medical Center (Miami Beach, FL); Mount Sinai Comprehensive Cancer Center at Aventura (Aventura, FL)

    Distance to nearest recruiting site
    ~4 mi (city-level)
    Recruiting sites
    4 sites within 50 mi

FAQ

Common questions

What is a clinical trial?
A clinical trial is a research study in people that tests a medical, surgical or behavioral intervention, such as an investigational drug or device. Observational studies are also listed: they collect information without assigning a treatment. Read how clinical trials work.
Is there compensation for joining a Breast Cancer clinical trial?
Compensation for time and travel may be available, but it varies by study and some studies offer none. The amount and schedule are reviewed by an ethics board and described in the consent form. See compensation in clinical trials.
How do I check if I'm eligible?
Each study lists age, sex and other inclusion and exclusion criteria on its ClinicalTrials.gov record. Only the study team can confirm eligibility, usually through a screening call or visit. Talk with your own doctor before joining any study.

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.